A patient calls the front desk and asks about a 50-gram vitamin C IV because she read it would help her not get colds this winter. Same week, an oncology patient asks whether the IV vitamin C protocol her integrative provider mentioned is something I can administer between her chemo cycles. Same week, a 38-year-old with persistent post-viral fatigue asks if a high-dose vitamin C drip might help her get back to her baseline.
Three completely different conversations, three completely different answers. Two of those patients should probably be getting the IV. One of them probably should not. The marketing around high-dose IV vitamin C does not draw those distinctions, which is part of why so many patients end up paying for an infusion that does not match what they are actually trying to accomplish.
In my 17 years of clinical work — emergency medicine, cardiac ICU, cath lab — I have administered a lot of IV therapy. I have a low tolerance for infusions handed out without a clinical reason and a strong respect for what targeted IV therapy can do when the indication is real. High-dose vitamin C sits squarely in the territory where the indication matters more than the dose.
What "high dose" actually means and why oral does not get you there
Oral vitamin C absorption is capped by saturable intestinal transporters. Above about 200 mg per dose, fractional absorption drops sharply. Above 1 gram, you are losing most of what you swallow to the stool. Plasma ascorbate from oral dosing tops out somewhere around 220 micromolar, no matter how aggressive the oral regimen. That ceiling is a physiological feature of the gut, not a problem with the supplement.
IV hydration therapy bypasses the gut entirely. A 25-gram infusion of ascorbic acid can push plasma levels into the 10,000 to 15,000 micromolar range. A 50- to 75-gram infusion can push it higher. At those concentrations, vitamin C stops behaving like a vitamin and starts behaving like a pro-oxidant — which, paradoxically, is the entire point of the high-dose protocol.
This is the mechanism most patients are not told about. At physiologic levels, vitamin C is an antioxidant. At pharmacologic levels achievable only by IV, it generates hydrogen peroxide in the extracellular space. Healthy cells with intact catalase activity neutralize the peroxide easily. Cells with reduced catalase activity — including most cancer cells, and tissues in certain inflammatory states — are less able to clear it. The selective oxidative stress is the proposed therapeutic mechanism in the oncology literature.
For routine wellness use, you do not need pharmacologic levels. A 5- to 15-gram infusion will produce a transient supraphysiologic plasma level without crossing into the oxidative range. That is a different protocol with different goals.
Where the evidence actually supports high-dose vitamin C
Honest summary of what the literature shows, not what the marketing suggests:
Adjunct in active cancer care, by referral or in coordination with oncology. There is reasonable Phase I and II data showing safety and possible quality-of-life benefit in patients receiving high-dose IVC alongside conventional treatment. The mechanism (selective pro-oxidant activity in malignant cells) is biologically plausible. This is a referral-based use case for me — I do not initiate it independently of a treating oncologist, and I want documentation of the treatment plan.
Severe post-viral and post-infectious fatigue states. The body's ascorbate stores are depleted by acute infection, and replenishment with IV dosing in patients who have struggled to recover often produces meaningful subjective improvement. The mechanism is a combination of antioxidant restoration, support for endogenous catecholamine and cortisol synthesis (both ascorbate-dependent), and likely some immune modulation.
Documented absorption failure. Patients post-bariatric surgery, patients with severe IBD, patients with severe SIBO, patients on long-term PPI therapy with confirmed low ascorbate levels. Oral repletion is unreliable in these patients. IV dosing is the only way to actually restore tissue stores.
Acute high-demand states. Sepsis is the cleanest example, though that is usually being addressed in hospital. Severe burns, major surgical recovery, certain inflammatory flares. IV dosing in these states has reasonable supportive evidence.
Routine wellness use in healthy patients with normal gut function. The honest answer is that the evidence here is weak. A 10-gram infusion in an otherwise healthy 35-year-old will produce a transient plasma elevation that excretes within 24 hours. The patient may feel an acute boost, partly from the hydration, partly from the saline magnesium content if it is in the bag, partly from genuine ascorbate effect, partly from expectation. The marginal benefit over a competent oral regimen is small.
I tell patients in this last category honestly. Some still want the infusion, and that is a reasonable adult decision. But I am not going to tell them it is medical when it is mostly recreational.
The screening I do before any high-dose vitamin C infusion
Not sure where to start?
The Start Here pathway walks you through the most common entry points and helps you decide which consultation type is the right fit. Five minutes of self-assessment can save you a wrong-direction conversation.
This is non-negotiable in my practice and it is the question to ask any IV provider before they push a high-dose protocol on you.
G6PD deficiency screening. Glucose-6-phosphate dehydrogenase deficiency affects about 5 to 10% of the male population in some demographic groups and is the single most important contraindication to high-dose IV vitamin C. The peroxide generated at pharmacologic doses can trigger acute hemolysis in G6PD-deficient red blood cells. The result is hemoglobinuria, acute kidney injury, and in severe cases hospitalization. I do not run a high-dose protocol on any patient who has not had a documented G6PD level. The test costs around $50 and takes a week to come back.
Renal function. Vitamin C is excreted renally, and a fraction is metabolized to oxalate. Patients with significant renal impairment can develop oxalate nephropathy from repeated high-dose infusions. Baseline creatinine and eGFR before initiating any high-dose course.
Iron overload screening. Vitamin C increases iron absorption and mobilization. Patients with hemochromatosis or significant iron overload should not receive high-dose ascorbate without iron status being addressed.
Medication interactions. High-dose vitamin C can interfere with certain chemotherapy agents, with copper chelation in Wilson's disease, and with point-of-care glucose meters (which can read falsely elevated for several hours after a high-dose infusion — relevant for diabetic patients).
Hydration status and electrolytes. A 50-gram infusion is a meaningful osmotic load. Patients dehydrated at baseline get a slower titration with adequate fluid loading.
If a clinic offers you a high-dose vitamin C drip without asking about any of this, that tells you something about how seriously they are taking the safety side.
How I actually use it in my practice
For most of my wellness patients, I am not running 50-gram protocols. I am running 5 to 15 grams as part of a targeted infusion built for what they actually need — often combined with B-complex, magnesium, and sometimes glutathione. That dose range produces meaningful plasma elevation, supports antioxidant capacity and catecholamine synthesis, and does not require the same screening intensity as the pharmacologic doses.
For post-viral or post-infectious fatigue patients, I usually run a series — 15 to 25 grams every 5 to 7 days for three to four sessions, then reassess. If symptoms have improved meaningfully, the schedule extends. If they have not, I stop the IV course and look for what we missed in the workup.
For oncology adjunct cases, I follow the protocol the treating oncologist has specified, in coordination with their team. I am not the primary clinician on those cases.
For "I just want a vitamin C drip because I read it was good" — I have the conversation. Sometimes the right answer is a smaller, more reasonable infusion. Sometimes the right answer is an oral regimen. Sometimes the right answer is none of the above, and what the patient actually needs is a comprehensive wellness assessment to figure out why she keeps getting sick or why her energy is off.
How I evaluate whether an infusion is the right tool
Before I add a patient to the IV schedule, the questions I ask:
- What specific outcome are you trying to achieve?
- What have you already tried orally, at what doses, for how long?
- What is your gut function — any history of IBD, post-surgical changes, chronic PPI use?
- Do you have a recent comprehensive panel? Ferritin, vitamin D, B12, magnesium, ascorbate if available?
- Are there hormonal or metabolic factors that have not been addressed and that might explain what you are trying to fix?
- What medications are you on?
If the answers point to a clean indication, I run the infusion at the appropriate dose with the appropriate screening. If the answers point to an unaddressed underlying problem, the IV is going to disappoint regardless of what is in the bag, and the right answer is to address the underlying problem first. I have watched patients spend thousands of dollars on weekly drips that were never going to work because the actual driver of their symptoms was untreated hypothyroidism or unaddressed perimenopause that needed hormone optimization instead.
Concrete next step
If high-dose IV vitamin C has come up in your reading and you want to know whether it is a reasonable fit for your situation, the right starting point is the brief intake conversation, not booking the infusion sight-unseen. Bring a recent CBC and metabolic panel if you have one. If you do not have a documented G6PD result, expect that I will order it before any pharmacologic-dose infusion. Schedule the intake at the Columbus IV clinic or Warner Robins IV clinic, or schedule an infusion at the wellness-dose level if you already know that is what you are looking for. We figure out what you actually need, then build the protocol from there.
Medical disclaimer: This article is for educational purposes only and does not constitute medical advice. Individual clinical decisions should be made in consultation with a qualified healthcare provider following appropriate evaluation. References to specific treatments, dosing, or protocols are informational.
Travis spent 17+ years in high-acuity clinical medicine — emergency, cardiac ICU, and cath lab — before founding Revitalize. He is a Certified Platinum Biote hormone therapy provider, the published author of You're Not Broken — You're Unbalanced, and the founder of the Rebuild Metabolic Health Institute. His clinical writing reflects the same precision he brought to critical care: specific, honest, and built around what actually works.
Ready to talk it through with a clinician?
Book online or call either Georgia location. Every visit starts with a consultation.